Zydus Cadila gets tentative US FDA nod for Osimertinib Tablets EP News Bureau Jun 3, 2021 Osimertinib is a kinase inhibitor used to treat lung cancer
US FDA approves Retevmo for lung, thyroid cancers with certain genetic mutations EP News Bureau May 9, 2020 It is the first therapy approved specifically for cancer patients with the RET gene alterations
AstraZeneca’s Imfinzi gets FDA priority review for small cell lung cancer Reuters Nov 29, 2019 The company said the FDA accepted its supplemental application and granted priority review to Imfinzi for the treatment of…
AstraZeneca’s Tagrisso helps lung cancer patients live longer: study Reuters Aug 9, 2019 The British drugmaker announced overall positive survival results from the study in patients with epidermal growth factor…